The weekly litigation news digest is live. Subscribe now

IP Verse

Crispr-Based Genome Modification And Regulation - EP3138912

The patent EP3138912 was granted to Sigma Aldrich on Dec 5, 2018. The application was filed on Dec 5, 2013 under application number EP16183725A. The patent is currently recorded with a legal status of "Revoked".

EP3138912

SIGMA ALDRICH
Application Number
EP16183725A
Filing Date
Dec 5, 2013
Status
Revoked
Aug 26, 2022
Publication Date
Dec 5, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
POHLMANSep 5, 2019POHLMANADMISSIBLE
BASFSep 4, 2019EISENFUHR SPEISERADMISSIBLE
BAYER BAYERJun 18, 2019COHAUSZ & FLORACKADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 22, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
GRUNDJan 30, 2019GRUNDADMISSIBLE
SCHLICHDec 6, 2018SCHLICHADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2011146121
OPPOSITIONWO2012087756
OPPOSITIONWO2013176772
OPPOSITIONWO2014089290
OTHEREP3138910
OTHERWO2011146121
OTHERWO2013176772
SEARCHWO2013176772
SEARCHWO2014093655
SEARCHWO2014099744

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents